Skip to main content
Kevin Kuntz, MD, Psychiatry, Madison, WI, Rogers Behavioral Health

KevinDKuntzMD

Psychiatry Madison, WI

Associate Professor, Psychiatry, University of Wisconsin Medical School

Are you Dr. Kuntz?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 39 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Kevin Kuntz, MD is a board certified psychiatrist in Madison, Wisconsin. He is currently licensed to practice medicine in Wisconsin and Vermont. He is affiliated with Rogers Behavioral Health and is an Associate Professor at University of Wisconsin Medical School.

Education & Training

  • University of Vermont Medical Center
    University of Vermont Medical CenterResidency, Psychiatry, 1990 - 1994
  • University of Iowa Roy J. and Lucille A. Carver College of Medicine
    University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1990

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 1994 - 2025
  • VT State Medical License
    VT State Medical License 1990 - 1994
  • American Board of Psychiatry and Neurology Psychiatry

Press Mentions

  • Ziopharm Finds New CEO After Six-Month Search; CFO Transition at Lonza to Take Place in December
    Ziopharm Finds New CEO After Six-Month Search; CFO Transition at Lonza to Take Place in DecemberSeptember 3rd, 2021
  • Ribon Therapeutics Presents Additional Preclinical Data on Its PARP7 Inhibitor – RBN-2397 – and Demonstrates Broad Potential of Its Platform at the AACR 2020 Virtual Meeting II
    Ribon Therapeutics Presents Additional Preclinical Data on Its PARP7 Inhibitor – RBN-2397 – and Demonstrates Broad Potential of Its Platform at the AACR 2020 Virtual Meeting IIJune 22nd, 2020
  • Ribon Therapeutics Presents Preclinical Data from Its PARP7 and PARP14 Programs at AACR Virtual Meeting I
    Ribon Therapeutics Presents Preclinical Data from Its PARP7 and PARP14 Programs at AACR Virtual Meeting IApril 27th, 2020

Hospital Affiliations